标题/作者	年份
Mechanisms of temozolomide resistance in glioblastoma-a comprehensive review N Singh, A Miner, L Hennis, S Mittal Cancer drug resistance 4 (1), 17	2021
Prognostic and predictive biomarkers in gliomas P Śledzińska, MG Bebyn, J Furtak, J Kowalewski, MA Lewandowska International journal of molecular sciences 22 (19), 10373	2021
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. MS Tomar, A Kumar, C Srivastava, A Shrivastava Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (2), 188616	2021
Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition R Yi, H Wang, C Deng, X Wang, L Yao, W Niu, M Fei, W Zhaba Bioscience Reports 40 (6), BSR20193314	2020
The plant-derived compound resveratrol in brain cancer: a review T Kiskova, P Kubatka, D Büsselberg, M Kassayova Biomolecules 10 (1), 161	2020
A potential mechanism of temozolomide resistance in glioma–ferroptosis Z Hu, Y Mi, H Qian, N Guo, A Yan, Y Zhang, X Gao Frontiers in oncology 10, 897	2020
A risk signature with four autophagy‐related genes for predicting survival of glioblastoma multiforme Y Wang, W Zhao, Z Xiao, G Guan, X Liu, M Zhuang Journal of Cellular and Molecular Medicine 24 (7), 3807-3821	2020
Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma C Ding, X Yi, X Chen, Z Wu, H You, X Chen, G Zhang, Y Sun, X Bu, X Wu, ... Journal of Experimental & Clinical Cancer Research 40 (1), 164	2021
RSL3 drives ferroptosis through NF-κB pathway activation and GPX4 depletion in glioblastoma S Li, Y He, K Chen, J Sun, L Zhang, Y He, H Yu, Q Li Oxidative Medicine and Cellular Longevity 2021	2021
DNA methylation and hydroxymethylation in cervical cancer: diagnosis, prognosis and treatment H Zhu, H Zhu, M Tian, D Wang, J He, T Xu Frontiers in Genetics 11, 347	2020
Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells E Gjika, S Pal-Ghosh, ME Kirschner, L Lin, JH Sherman, MA Stepp, ... Scientific Reports 10 (1), 16495	2020
Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments P Maiti, A Plemmons, GL Dunbar PloS one 14 (12), e0225660	2019
GLI1: a therapeutic target for cancer JT Avery, R Zhang, RJ Boohaker Frontiers in Oncology 11, 673154	2021
TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ H Lu, J Xiao, C Ke, X Ni, R Xiu, Q Tian, H Pan, L Zou, F Wang, T Ma, X Ji, ... Cell death & disease 10 (8), 583	2019
CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells Y Cao, X Li, S Kong, S Shang, Y Qi Journal of cellular and molecular medicine 24 (9), 5135-5145	2020
The dual roles of autophagy in gliomagenesis and clinical therapy strategies based on autophagic regulation mechanisms F Feng, M Zhang, C Yang, X Heng, X Wu Biomedicine & Pharmacotherapy 120, 109441	2019
A drug screening pipeline using 2D and 3D patient-derived in vitro models for pre-clinical analysis of therapy response in glioblastoma S Lenin, E Ponthier, KG Scheer, ECF Yeo, MN Tea, LM Ebert, ... International Journal of Molecular Sciences 22 (9), 4322	2021
Identification of prognostic model and biomarkers for cancer stem cell characteristics in glioblastoma by network analysis of multi-omics data and stemness indices J Du, X Yan, S Mi, Y Li, H Ji, K Hou, S Ma, Y Ba, P Zhou, L Chen, R Xie, ... Frontiers in cell and developmental biology 8, 558961	2020
MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9 TJ Xu, P Qiu, YB Zhang, SY Yu, GM Xu, W Yang Human cell 32 (4), 548-556	2019
Resveratrol as chemosensitizer agent: state of art and future perspectives V Cocetta, V Quagliariello, F Fiorica, M Berretta, M Montopoli International Journal of Molecular Sciences 22 (4), 2049	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。